Speech Pathology Australia Annual Report 2023

STATEMENT OF CHANGES IN EQUITY

For the year ended 31 December 2023

Retained surplus Total equity $ $

Balance at 1 January 2022 Net surplus/(deficit) for the year Other comprehensive income Balance at 31 December 2022 Net surplus/(deficit) for the year Other comprehensive income Total comprehensive income for the year Total comprehensive income for the year

3,553,570 (591,263)

3,553,570 (591,263)

-

-

(591,263) 2,962,307 (374,959

(591,263) 2,962,307 (374,959)

-

-

(374,959) 2,587,348

(374,959) 2,587,348

Balance at 31 December 2023

This statement should be read in conjunction with the notes to the financial statements.

STATEMENT OF CASH FLOWS

For the year ended 31 December 2023

Notes 2023

2022

$

$

OPERATING SERVICES Receipts from Member Services

9,940,200 8,353,925

Payments to members, suppliers and employees

(9,518,726) (10,236) 146,708 (27,181) 530,765 (173,675) (473,784) (647,459) (199,794) (199,794) (316,488)

(8,851,516)

Income tax paid Interest received

(5,612) 32,879 (1,187)

Interest paid

Net cash provided by/(used in) operating activities INVESTING ACTIVITIES Proceeds from redemption of/(payment for) financial assets

(471,511)

82,381

Purchase of property, plant and equipment

(41,601)

Net cash provided by/(used in) investing activities

40,780

FINANCING ACTIVITIES Repayment of lease liability

(313,060) (313,060) (743,791)

Net cash provided by/(used in) financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year

2,476,407 3,220,198 2,159,919 2,476,407

6

This statement should be read in conjunction with the notes to the financial statements.

30 Speech Pathology Australia | 2023 Annual Report